# eHealth, Inc.: financial statements, quarterly

EHTH · Nasdaq · CIK 1333493 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ehth.md) · [Financials](/companies/ehth/financials.md) · [Filings](/companies/ehth/filings.md) · [Insiders](/companies/ehth/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ehth/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [64.7](/filings/0001333493-24-000173.md) | [248 d](/filings/0001333493-25-000027.md) | [93.0](/filings/0001333493-25-000057.md) | [65.9](/filings/0001333493-25-000094.md) | [58.4](/filings/0001333493-25-000111.md) | [315 d](/filings/0001333493-26-000010.md) | [113](/filings/0001333493-26-000027.md) | [60.8](/filings/0001333493-26-000036.md) | [53.9](/filings/0001333493-25-000111.md) | [326 d](/filings/0001333493-26-000010.md) | [88.0](/filings/0001333493-26-000027.md) | [33.6](/filings/0001333493-26-000036.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | [29.5](/filings/0001333493-25-000057.md) | [18.9](/filings/0001333493-25-000094.md) | [(3.8)](/filings/0001333493-25-000111.md) | [164 d](/filings/0001333493-26-000010.md) | [41.7](/filings/0001333493-26-000027.md) | [18.9](/filings/0001333493-26-000036.md) | [(0.2)](/filings/0001333493-25-000111.md) | [180 d](/filings/0001333493-26-000010.md) | [36.7](/filings/0001333493-26-000027.md) | [5.1](/filings/0001333493-26-000036.md) |
| Operating income | $m | [(39.4)](/filings/0001333493-24-000173.md) | [59.4 d](/filings/0001333493-25-000027.md) | [(17.9)](/filings/0001333493-25-000057.md) | [(28.0)](/filings/0001333493-25-000094.md) | [(43.2)](/filings/0001333493-25-000111.md) | [113 d](/filings/0001333493-26-000010.md) | [4.8](/filings/0001333493-26-000027.md) | [(23.0)](/filings/0001333493-26-000036.md) | [(41.5)](/filings/0001333493-25-000111.md) | [126 d](/filings/0001333493-26-000010.md) | [(2.9)](/filings/0001333493-26-000027.md) | [(27.5)](/filings/0001333493-26-000036.md) |
| Interest expense | $m | [2.8](/filings/0001333493-24-000173.md) | [2.9 d](/filings/0001333493-24-000032.md) | [2.8](/filings/0001333493-24-000074.md) | [2.8](/filings/0001333493-25-000094.md) | [2.9](/filings/0001333493-25-000111.md) | [2.6 d](/filings/0001333493-26-000010.md) | [2.6](/filings/0001333493-26-000027.md) | [2.3](/filings/0001333493-26-000036.md) | [2.4](/filings/0001333493-25-000111.md) | [3.4 d](/filings/0001333493-26-000010.md) | [4.0](/filings/0001333493-26-000027.md) | [4.1](/filings/0001333493-26-000036.md) |
| Income tax | $m | [(2.5)](/filings/0001333493-24-000173.md) | [6.3 d](/filings/0001333493-25-000027.md) | [(1.3)](/filings/0001333493-25-000057.md) | [(0.5)](/filings/0001333493-25-000094.md) | [(1.9)](/filings/0001333493-25-000111.md) | [13.0 d](/filings/0001333493-26-000010.md) | [1.8](/filings/0001333493-26-000027.md) | [(6.7)](/filings/0001333493-26-000036.md) | [(11.2)](/filings/0001333493-25-000111.md) | [34.8 d](/filings/0001333493-26-000010.md) | [(1.4)](/filings/0001333493-26-000027.md) | [(7.1)](/filings/0001333493-26-000036.md) |
| Net income | $m | [(37.0)](/filings/0001333493-24-000173.md) | [52.2 d](/filings/0001333493-25-000027.md) | [(17.0)](/filings/0001333493-25-000111.md) | [(28.0)](/filings/0001333493-25-000111.md) | [(42.5)](/filings/0001333493-25-000111.md) | [97.5 d](/filings/0001333493-26-000010.md) | [2.0](/filings/0001333493-26-000036.md) | [(17.4)](/filings/0001333493-26-000036.md) | [(31.7)](/filings/0001333493-25-000111.md) | [87.2 d](/filings/0001333493-26-000010.md) | [(4.7)](/filings/0001333493-26-000036.md) | [(23.6)](/filings/0001333493-26-000036.md) |
| Diluted EPS | $ per share | [(1.68)](/filings/0001333493-24-000173.md) | not reported | [(0.96)](/filings/0001333493-25-000057.md) | [(1.33)](/filings/0001333493-25-000094.md) | [(1.83)](/filings/0001333493-25-000111.md) | not reported | [(0.33)](/filings/0001333493-26-000027.md) | [(0.98)](/filings/0001333493-26-000036.md) | [(1.46)](/filings/0001333493-25-000111.md) | not reported | [(0.58)](/filings/0001333493-26-000027.md) | [(1.18)](/filings/0001333493-26-000036.md) |
| Basic EPS | $ per share | [(1.68)](/filings/0001333493-24-000173.md) | not reported | [(0.96)](/filings/0001333493-25-000057.md) | [(1.33)](/filings/0001333493-25-000094.md) | [(1.83)](/filings/0001333493-25-000111.md) | not reported | [(0.33)](/filings/0001333493-26-000027.md) | [(0.98)](/filings/0001333493-26-000036.md) | [(1.46)](/filings/0001333493-25-000111.md) | not reported | [(0.58)](/filings/0001333493-26-000027.md) | [(1.18)](/filings/0001333493-26-000036.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating, us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [152](/filings/0001333493-23-000141.md) | [116](/filings/0001333493-25-000027.md) | [175](/filings/0001333493-24-000074.md) | [126](/filings/0001333493-24-000126.md) | [64.0](/filings/0001333493-24-000173.md) | [39.2](/filings/0001333493-26-000010.md) | [121](/filings/0001333493-25-000057.md) | [65.9](/filings/0001333493-25-000094.md) | [63.1](/filings/0001333493-25-000111.md) | [73.7](/filings/0001333493-26-000036.md) | [75.1](/filings/0001333493-26-000027.md) | [69.7](/filings/0001333493-26-000036.md) |
| Current assets | $m | [397](/filings/0001333493-23-000141.md) | [382](/filings/0001333493-25-000027.md) | [404](/filings/0001333493-24-000074.md) | [356](/filings/0001333493-24-000126.md) | [341](/filings/0001333493-24-000173.md) | [354](/filings/0001333493-26-000010.md) | [369](/filings/0001333493-25-000057.md) | [328](/filings/0001333493-25-000094.md) | [303](/filings/0001333493-25-000111.md) | [334](/filings/0001333493-26-000036.md) | [337](/filings/0001333493-26-000027.md) | [316](/filings/0001333493-26-000036.md) |
| Total assets | $m | [1,026](/filings/0001333493-23-000141.md) | [1,113](/filings/0001333493-25-000027.md) | [1,096](/filings/0001333493-24-000074.md) | [1,039](/filings/0001333493-24-000126.md) | [1,002](/filings/0001333493-24-000173.md) | [1,155](/filings/0001333493-26-000010.md) | [1,137](/filings/0001333493-25-000057.md) | [1,080](/filings/0001333493-25-000094.md) | [1,047](/filings/0001333493-25-000111.md) | [1,262](/filings/0001333493-26-000036.md) | [1,201](/filings/0001333493-26-000027.md) | [1,158](/filings/0001333493-26-000036.md) |
| Current liabilities | $m | [53.2](/filings/0001333493-23-000141.md) | [78.5](/filings/0001333493-25-000027.md) | [146](/filings/0001333493-24-000074.md) | [116](/filings/0001333493-24-000126.md) | [53.8](/filings/0001333493-24-000173.md) | [96.0](/filings/0001333493-26-000010.md) | [143](/filings/0001333493-25-000057.md) | [110](/filings/0001333493-25-000094.md) | [51.2](/filings/0001333493-25-000111.md) | [99.1](/filings/0001333493-26-000036.md) | [44.3](/filings/0001333493-26-000027.md) | [31.7](/filings/0001333493-26-000036.md) |
| Total liabilities | $m | [178](/filings/0001333493-23-000141.md) | [209](/filings/0001333493-25-000027.md) | [205](/filings/0001333493-24-000074.md) | [173](/filings/0001333493-24-000126.md) | [176](/filings/0001333493-24-000173.md) | [229](/filings/0001333493-26-000010.md) | [208](/filings/0001333493-25-000057.md) | [166](/filings/0001333493-25-000094.md) | [163](/filings/0001333493-25-000111.md) | [289](/filings/0001333493-26-000036.md) | [231](/filings/0001333493-26-000027.md) | [211](/filings/0001333493-26-000036.md) |
| Long-term debt | $m | [67.3](/filings/0001333493-23-000141.md) | [67.8](/filings/0001333493-25-000027.md) | [0.0](/filings/0001333493-24-000074.md) | [0.0](/filings/0001333493-24-000126.md) | [69.2](/filings/0001333493-24-000173.md) | [68.5](/filings/0001333493-26-000010.md) | [0.0](/filings/0001333493-25-000057.md) | [0.0](/filings/0001333493-25-000094.md) | [69.4](/filings/0001333493-25-000111.md) | [113](/filings/0001333493-26-000036.md) | [114](/filings/0001333493-26-000027.md) | [115](/filings/0001333493-26-000036.md) |
| Short-term borrowings | $m | not reported | [0.0](/filings/0001333493-24-000126.md) | [68.2](/filings/0001333493-24-000074.md) | [68.7](/filings/0001333493-24-000126.md) | not reported | [0.0](/filings/0001333493-25-000094.md) | [68.8](/filings/0001333493-25-000057.md) | [69.1](/filings/0001333493-25-000094.md) | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [560](/filings/0001333493-24-000173.md) | [606](/filings/0001333493-26-000010.md) | [583](/filings/0001333493-25-000111.md) | [549](/filings/0001333493-25-000111.md) | [499](/filings/0001333493-25-000111.md) | [588](/filings/0001333493-26-000036.md) | [582](/filings/0001333493-26-000036.md) | [555](/filings/0001333493-26-000036.md) | [514](/filings/0001333493-25-000111.md) | [592](/filings/0001333493-26-000036.md) | [576](/filings/0001333493-26-000036.md) | [541](/filings/0001333493-26-000036.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(24.7) d](/filings/0001333493-24-000173.md) | [(33.4) d](/filings/0001333493-25-000027.md) | [70.8](/filings/0001333493-25-000057.md) | [(32.2) d](/filings/0001333493-25-000094.md) | [(29.3) d](/filings/0001333493-25-000111.md) | [(27.7) d](/filings/0001333493-26-000010.md) | [77.1](/filings/0001333493-26-000027.md) | [(41.2) d](/filings/0001333493-26-000036.md) | [(25.3) d](/filings/0001333493-25-000111.md) | [(35.9) d](/filings/0001333493-26-000010.md) | [35.8](/filings/0001333493-26-000027.md) | [(5.0) d](/filings/0001333493-26-000036.md) |
| Capital expenditure | $m | [1.4 d](/filings/0001333493-24-000173.md) | [0.3 d](/filings/0001333493-25-000027.md) | [0.2](/filings/0001333493-25-000057.md) | [0.3 d](/filings/0001333493-25-000094.md) | [1.0 d](/filings/0001333493-25-000111.md) | [0.6 d](/filings/0001333493-26-000010.md) | [0.3](/filings/0001333493-26-000027.md) | [1.6 d](/filings/0001333493-26-000036.md) | [0.2 d](/filings/0001333493-25-000111.md) | [0.1 d](/filings/0001333493-26-000010.md) | [0.2](/filings/0001333493-26-000027.md) | [0.5 d](/filings/0001333493-26-000036.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [27.3](/filings/0001333493-23-000141.md) | [27.6](/filings/0001333493-24-000074.md) | [27.8](/filings/0001333493-24-000126.md) | [28.1](/filings/0001333493-24-000173.md) | [28.9](/filings/0001333493-25-000057.md) | [29.2](/filings/0001333493-25-000094.md) | [29.5](/filings/0001333493-25-000111.md) | [30.0](/filings/0001333493-26-000027.md) | [30.4](/filings/0001333493-26-000036.md) | [30.6](/filings/0001333493-25-000111.md) | [31.1](/filings/0001333493-26-000027.md) | [31.8](/filings/0001333493-26-000036.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 32,032,654 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001333493-26-000036.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.